Načítá se...
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
The COVID-19 pandemic is a major threat to global health for which there are only limited medical countermeasures, and we lack a thorough understanding of mechanisms of humoral immunity (1,2) . From a panel of monoclonal antibodies (mAbs) targeting the spike (S) glycoprotein isolated from the B cell...
Uloženo v:
| Vydáno v: | bioRxiv |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7263556/ https://ncbi.nlm.nih.gov/pubmed/32511409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.22.111005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|